赛伦生物: 赛伦生物：关于完成工商变更登记并换发营业执照的公告

Core Points - The company has completed the registration of changes in business operations and has obtained a new business license [2] - The company held board and shareholder meetings to approve the cancellation of the supervisory board and amendments to the articles of association [1][2] - The updated business scope includes drug production, import and export, and various medical device operations [2] Group 1 - The company held its fourth board meeting on July 24, 2025, and the first extraordinary general meeting on August 11, 2025, to approve significant changes [1] - The new registered capital of the company is RMB 108.22 million [2] - The company is now registered as a joint-stock company with a unified social credit code of 91310000631521822M [2] Group 2 - The company's business scope now includes the production and sale of various classes of medical devices and drug-related services [2] - The company is authorized to engage in technology services, development, consulting, and investment management [2] - The registered address of the company is located at 1288 Huqing Road, Qingpu District, Shanghai [2]